C. Cornelisse

发表

Chromosome 9 alterations and trisomy 22 in central chondrosarcoma: a cytogenetic and DNA flow cytometric analysis of chondrosarcoma subtypes.

P. Cin, R. Sciot, M. Debiec‐Rychter, 2001, Diagnostic molecular pathology : the American journal of surgical pathology, part B.

Genetic alterations on chromosome 16 and 17 are important features of ductal carcinoma in situ of the breast and are associated with histologic type

J. Peterse, M. Vijver, A. Cleton-Jansen, 1999, British Journal of Cancer.

E-cadherin is inactivated in a majority of invasive human lobular breast cancers by truncation mutations throughout its extracellular domain.

G. Berx, A. Cleton-Jansen, F. van Roy, 1996, Oncogene.

Evidence for limited molecular genetic heterogeneity as defined by allelotyping and clonal analysis in nine metastatic breast carcinomas.

G. Fleuren, P. Devilee, A. Cleton-Jansen, 1993, Cancer research.

Ploidy of primary germ cell tumors of the testis. Pathogenetic and clinical relevance.

D. Sleijfer, C. Cornelisse, J. Oosterhuis, 1989, Laboratory investigation; a journal of technical methods and pathology.

Screening for BRCA2 mutations in 81 Dutch breast–ovarian cancer families

M. Stratton, G. Bignell, J. Klijn, 1999, British Journal of Cancer.

Atypical HNPCC owing to MSH6 germline mutations: analysis of a large Dutch pedigree

A. Zwinderman, R. Hofstra, A. Wagner, 2001, Journal of medical genetics.

Isolation of two distinct epithelial cell lines from a single feline mammary carcinoma with different tumorigenic potential in nude mice and expressing different levels of epidermal growth factor receptors.

J. Stolwijk, E. Schuuring, R. van den Berghe, 1991, Cancer research.

4.1. CHARACTERIZATION OF FAMILIAL NON-BRCA1/2 BREAST TUMORS BY LOSS OF HETEROZYGOSIT Y AND IMMUNOPHENOT YPING

P. Devilee, H. Meijers-Heijboer, H. Morreau, 2008 .

High prevalence of founder mutations of the succinate dehydrogenase genes in the Netherlands

P. Devilee, E. Corssmit, C. Cornelisse, 2012, Clinical genetics.

Near-haploidy and subsequent polyploidization characterize the progression of peripheral chondrosarcoma.

A. Cleton-Jansen, P. Hogendoorn, J. Bovée, 2000, The American journal of pathology.

Mutation analysis of the Fanconi anaemia A gene in breast tumours with loss of heterozygosity at 16q24.3

C. Mathew, A. Cleton-Jansen, D. Callen, 1999, British Journal of Cancer.

SDHD mutations in head and neck paragangliomas result in destabilization of complex II in the mitochondrial respiratory chain with loss of enzymatic activity and abnormal mitochondrial morphology

P. Hogendoorn, C. Cornelisse, S. V. van Duinen, 2003, The Journal of pathology.

E‐cadherin is a tumour/invasion suppressor gene mutated in human lobular breast cancers.

M. Vijver, G. Berx, A. Cleton-Jansen, 1995, The EMBO journal.

Early diagnosis of mycosis fungoides and Sézary's syndrome by morphometric analysis of lymphoid cells in the skin

E Scheffer, E. van der Velde, C. Meijer, 1980, Cancer.

PLOIDY OF SUBTYPES OF PRIMARY GERM-CELL TUMORS OF THE TESTIS - PATHOGENETIC AND CLINICAL RELEVANCE

D. Sleijfer, C. Cornelisse, J. Oosterhuis, 1989 .

Histology and DNA contents of a secondary malignancy arising in a mature residual lesion six years after chemotherapy for a disseminated nonseminomatous testicular tumor

C. Cornelisse, J. Oosterhuis, H. Koops, 1986, Cancer.

© 1997 Cancer Research Campaign

M. J. van de Vijver, J. Peterse, G. Berx, 2022 .

E-cadherin transcriptional downregulation by promoter methylation but not mutation is related to epithelial-to-mesenchymal transition in breast cancer cell lines

P. Eilers, A. Cleton-Jansen, B. van de Water, 2006, British Journal of Cancer.

Characterization and screening for mutations of the growth arrest-specific 11 (GAS11) and C16orf3 genes at 16q24.3 in breast cancer.

A D Auerbach, C. Mathew, N. Doggett, 1998, Genomics.

KRAS codon 12 mutations occur very frequently in pancreatic adenocarcinomas.

G. Fleuren, J. Bos, A. Smits, 1988, Nucleic acids research.

Aneurysmal bone cyst and telangiectatic osteosarcoma

D. Ruiter, C. Cornelisse, E. A. Velde, 1977, Virchows Archiv A.

Loss of heterozygosity mapping at chromosome arm 16q in 712 breast tumors reveals factors that influence delineation of candidate regions.

C. Mathew, A. Cleton-Jansen, D. Callen, 2001, Cancer research.

EXT-mutation analysis and loss of heterozygosity in sporadic and hereditary osteochondromas and secondary chondrosarcomas.

A. Cleton-Jansen, P. Hogendoorn, W. Hul, 1999, American journal of human genetics.

PCR artifacts in LOH and MSI analysis of microdissected tumor cells.

G. Fleuren, A. Cleton-Jansen, C. Cornelisse, 2000, Human pathology.

Differences in patterns of allelic loss between two common types of adult cancer, breast and colon carcinoma, and Wilms' tumor of childhood

P. Devilee, C. Cornelisse, A. Westerveld, 1991, International journal of cancer.

Tumour characteristics and prognosis of breast cancer patients carrying the germline CHEK2*1100delC variant

M. Schutte, R. Tollenaar, P. Devilee, 2004, Journal of Medical Genetics.

Three germline mutations in the TP53 gene

P. Devilee, P. Voûte, C. Cornelisse, 1997, Human mutation.

Age at diagnosis as an indicator of eligibility for BRCA1 DNA testing in familial breast cancer

P. Devilee, H. Meijers-Heijboer, D. Ford, 1995, Human Genetics.

DNA-aneuploidy in rhabdomyosarcomas as compared with other sarcomas of childhood and adolescence.

C. Cornelisse, W. Molenaar, W. Kamps, 1988, Human pathology.

Flow cytometric DNA ploidy analysis of ovarian granulosa cell tumors.

C. Cornelisse, S. Chadha, A. Schaberg, 1990, Gynecologic oncology.

Molecular genetic evidence for unifocal origin of advanced epithelial ovarian cancer and for minor clonal divergence.

S. Henzen‐Logmans, E. Berns, C. Cornelisse, 1995, British Journal of Cancer.

Possible consequences of applying guidelines to healthy women with a family history of breast cancer

W. E. Hoogendoorn, R. Tollenaar, P. Devilee, 2003, European Journal of Human Genetics.

Genome-wide scanning for linkage in 56 Dutch breast cancer families selected for a minimal probability of being due to BRCA1 or BRCA2

P. Devilee, H. Meijers-Heijboer, N. Hoogerbrugge, 2005, Breast Cancer Research.

Association between the CHEK2*1100delC germ line mutation and estrogen receptor status.

M. Schutte, R. Tollenaar, P. Devilee, 2006, International journal of gynecological cancer : official journal of the International Gynecological Cancer Society.

DNA flow cytometry and morphometry as prognostic indicators in advanced ovarian cancer: A step forward in predicting the clinical outcome

J. Hermans, C. Cornelisse, G. Fleuren, 1988, Gynecologic Oncology.

Prognostic factors in well‐differentiated early‐stage epithelial ovarian cancer

G. Fleuren, J. Trimbos, C. Cornelisse, 1993, Cancer.

PCR-based microsatellite polymorphisms in the detection of loss of heterozygosity in fresh and archival tumour tissue.

P. Devilee, C. Cornelisse, R. Frants, 1993, British Journal of Cancer.

Outgrowth of BT-474 human breast cancer cells in immune-deficient mice: a new in vivo model for hormone-dependent breast cancer.

C. Cornelisse, H. Smith, B. Bonsing, 1995, British Journal of Cancer.

Human papillomavirus type 16 in tumor tissue of low‐stage squamous carcinoma of the uterine cervix in relation to ploidy grade and prognosis

G. Fleuren, G. Kenter, C. Cornelisse, 1993, Cancer.

Flow cytometric DNA‐ploidy analysis of synchronously occurring multiple malignant tumors of the female genital tract

G. Fleuren, C. Cornelisse, V. Smit, 1990, Cancer.